Skip to main content
. 2017 Mar 22;31(7):2916–2924. doi: 10.1096/fj.201700001R

Figure 5.

Figure 5.

CRMP treatment reduced muscle triglyceride and DAG content but did not alter muscle ceramide content. A) Quadriceps TAG content. B, C) Quadriceps cytosol (B) and membrane (C) DAG content. D) Quadriceps ceramide content. E) PKC-θ translocation in muscle. Data are represented as means ± sem (n = 8 per group). Statistical significance determined by Student’s t test.